Patent · US Active

Electroprocessed collagen and tissue engineering

US8586345B2 · kind B2 · utility

39Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 21, 2011
Grant dateNov 19, 2013
Priority date
Expiry dateMar 21, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T442/614
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.